The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial

The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial

Abstract Background Hypercholesterolemia is one of the main risk factors for cardiovascular disease. The first line treatment for hypercholesterolemia is statin therapy. When the expected low-density lipoprotein cholesterol (LDL-C) concentration is not achieved, the pharmacotherapy may be extended b...

Full description

Bibliographic Details
Main Authors: Karolina Obońska, Michał Kasprzak, Joanna Sikora, Ewa Obońska, Krzysztof Racki, Natalia Goździkiewicz, Magdalena Krintus, Jacek Kubica
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Trials
Subjects:
Adherence
Cardiovascular risk
Coronary artery disease
Dyslipidemia
Ezetimibe
Hydroxymethylglutaryl-CoA
Online Access:http://link.springer.com/article/10.1186/s13063-017-2047-8

Internet

http://link.springer.com/article/10.1186/s13063-017-2047-8

Similar Items